1ABBV:BIT
AbbVie Common Stock
230,10 €
arrow_downward
-0,60%(-1,40) 1D
2 қаз., 17:26:00 GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 1ABBV...
Open
232,20 €
High
232,20 €
Low
230,10 €
Mkt. cap
488,93 млрд
Avg. vol.
38,00
Volume
26,00
52-wk high
234,90 €
52-wk low
168,00 €
No. of employees
57 мың
Open
232,20 €
High
232,20 €
Low
230,10 €
Mkt. cap
488,93 млрд
Avg. vol.
38,00
Volume
26,00
52-wk high
234,90 €
52-wk low
168,00 €
No. of employees
57 мың
News stories
From web sources and news partners
Fierce Biotech
·
2 сағат бұрын
Biotech builder Paragon imports Apogee's top brass after AbbVie buyout
Seeking Alpha
·
4 сағат бұрын
AbbVie, Eli Lilly among mega-cap healthcare stocks with A+ profitability grades (XLV:NYSEARCA)
Endpoints News
·
4 сағат бұрын
After $10.9B exit to AbbVie, Apogee execs join Paragon to scale its R&D, company creation engine
Yahoo Finance
·
8 сағат бұрын
AbbVie (ABBV) Could Be 44% Below Fair Value On Fresh Pipeline Wins
Profile
AbbVie Inc., also known as AbbVie, is an American pharmaceutical company headquartered in North Chicago, Illinois. AbbVie produces drugs to treat a wide range of medical issues.
The company is ranked sixth on the list of largest biomedical companies by revenue. It is ranked 77th on the Fortune 500 and 108th on the Forbes Global 2000. The name "AbbVie" is derived from a combination of "Abbott", the name of its former parent company, with "vie", intended as a reference to a Latin root meaning 'life'. Wikipedia
About AbbVie Common Stock
CEORobert A. Michael
Employees57 мың
Founded2012 ж. 10 сәу.
HeadquartersNorth Chicago, Иллинойс, Америка Құрама Штаттары
Sector-
Websiteabbvie.com